Susquehanna International Group, LLP Roivant Sciences Ltd. Transaction History
Susquehanna International Group, LLP
- $641 Billion
- Q4 2024
A detailed history of Susquehanna International Group, LLP transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 126,787 shares of ROIV stock, worth $1.39 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
126,787
Previous 310,007
59.1%
Holding current value
$1.39 Million
Previous $3.58 Million
58.09%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding ROIV
# of Institutions
326Shares Held
505MCall Options Held
573KPut Options Held
739K-
Qvt Financial LP New York, NY65.8MShares$724 Million76.3% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X062.1MShares$683 Million6.45% of portfolio
-
Viking Global Investors LP47.8MShares$526 Million1.91% of portfolio
-
Vanguard Group Inc Valley Forge, PA44.1MShares$485 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$389 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.75B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...